C4 Therapeutics Ownership 2024 | Who Owns C4 Therapeutics Now?


OverviewForecastRevenueFinancialsChart

Institutional Ownership

113.18%

Insider Ownership

11.74%

Retail Ownership

-24.93%

Institutional Holders

109.00

C4 Therapeutics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
STATE STREET CORP13.97%0.00%7,153,2806,997,9074503.94%58,442,298Mar 31, 2024
RA CAPITAL MANAGEMENT, L.P.9.52%0.06%4,878,000--39,853,260Mar 31, 2024
WASATCH ADVISORS LP8.45%0.18%4,328,479-2,810,470-39.37%35,363,673Mar 31, 2024
LYNX1 CAPITAL MANAGEMENT LP7.10%7.70%3,634,662500,26615.96%29,695,189Mar 31, 2024
COMMODORE CAPITAL LP6.66%1.86%3,410,384-389,616-10.25%27,862,837Mar 31, 2024
VANGUARD GROUP INC5.70%0.00%2,920,028920,62746.05%23,856,629Mar 31, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.4.80%1.49%2,458,996623,00033.93%20,089,997Mar 31, 2024
BALYASNY ASSET MANAGEMENT L.P.4.76%0.03%2,435,380731,11142.90%19,897,055Mar 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/4.13%0.00%2,115,477-443,003-17.32%17,284,000Mar 31, 2024
BANK OF AMERICA CORP /DE/3.62%0.00%1,855,158180,06110.75%15,156,641,000Mar 31, 2024
SILVERARC CAPITAL MANAGEMENT, LLC2.80%3.26%1,435,9311,435,931100.00%11,731,556Mar 31, 2024
TWO SIGMA ADVISERS, LP2.56%0.02%1,312,2001,239,5001704.95%10,720,674Mar 31, 2024
ARROWMARK COLORADO HOLDINGS LLC2.52%0.12%1,291,939-845,442-39.55%10,555,142Mar 31, 2024
GOLDMAN SACHS GROUP INC2.50%0.00%1,281,2421,167,7291028.72%10,467,747Mar 31, 2024
TCG CROSSOVER MANAGEMENT, LLC2.49%0.82%1,276,574--10,429,610Mar 31, 2024
TWO SIGMA INVESTMENTS, LP2.29%0.02%1,171,8401,171,840100.00%9,573,933Mar 31, 2024
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC2.23%0.75%1,142,210-500,000-30.45%9,331,856Mar 31, 2024
POINT72 ASSET MANAGEMENT, L.P.1.77%0.02%906,472-1,054,887-53.78%7,405,876Mar 31, 2024
BLACKROCK INC.1.77%0.00%905,006-898,427-49.82%7,393,899Mar 31, 2024
RAFFERTY ASSET MANAGEMENT, LLC1.63%0.03%833,681833,681100.00%6,811,174Mar 31, 2024

C4 Therapeutics's largest institutional shareholder is STATE STREET CORP, holding 13.97% of the company's total share outstanding, currently valued at $58.44M. The top 10 institutional shareholders own together 68.71% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
LYNX1 CAPITAL MANAGEMENT LP7.10%7.70%3,634,662500,26615.96%29,695,189Mar 31, 2024
SILVERARC CAPITAL MANAGEMENT, LLC2.80%3.26%1,435,9311,435,931100.00%11,731,556Mar 31, 2024
COMMODORE CAPITAL LP6.66%1.86%3,410,384-389,616-10.25%27,862,837Mar 31, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.4.80%1.49%2,458,996623,00033.93%20,089,997Mar 31, 2024
TCG CROSSOVER MANAGEMENT, LLC2.49%0.82%1,276,574--10,429,610Mar 31, 2024
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC2.23%0.75%1,142,210-500,000-30.45%9,331,856Mar 31, 2024
ATOM INVESTORS LP0.62%0.32%316,246316,246100.00%2,583,730Mar 31, 2024
ENTRYPOINT CAPITAL, LLC0.06%0.21%28,51628,516100.00%232,976Mar 31, 2024
WASATCH ADVISORS LP8.45%0.18%4,328,479-2,810,470-39.37%35,363,673Mar 31, 2024
ARROWMARK COLORADO HOLDINGS LLC2.52%0.12%1,291,939-845,442-39.55%10,555,142Mar 31, 2024
HARBOR CAPITAL ADVISORS, INC.0.19%0.10%96,96421,17027.93%792,000Mar 31, 2024
QUEST PARTNERS LLC0.13%0.09%64,00164,001100.00%522,888Mar 31, 2024
FOX RUN MANAGEMENT, L.L.C.0.08%0.07%41,73241,732100.00%340,950Mar 31, 2024
ARETE WEALTH ADVISORS, LLC0.17%0.06%85,20013,10018.17%696,084Mar 31, 2024
RA CAPITAL MANAGEMENT, L.P.9.52%0.06%4,878,000--39,853,260Mar 31, 2024
POLYMER CAPITAL MANAGEMENT (HK) LTD0.04%0.05%21,90621,906100.00%178,972Mar 31, 2024
PROFUND ADVISORS LLC0.25%0.04%126,250126,250100.00%1,031,463Mar 31, 2024
MARATHON TRADING INVESTMENT MANAGEMENT LLC0.13%0.04%64,00064,000100.00%522,880Mar 31, 2024
LAURION CAPITAL MANAGEMENT LP1.05%0.04%535,342535,342100.00%4,373,744Mar 31, 2024
TREXQUANT INVESTMENT LP0.44%0.04%224,487224,487100.00%1,834,059Mar 31, 2024

The largest C4 Therapeutics shareholder by % of total assets is LYNX1 CAPITAL MANAGEMENT LP. The company owns 3.63M shares of C4 Therapeutics (CCCC), representing 7.70% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
STATE STREET CORP13.97%0.00%7,153,2806,997,9074503.94%58,442,298Mar 31, 2024
SILVERARC CAPITAL MANAGEMENT, LLC2.80%3.26%1,435,9311,435,931100.00%11,731,556Mar 31, 2024
TWO SIGMA ADVISERS, LP2.56%0.02%1,312,2001,239,5001704.95%10,720,674Mar 31, 2024
TWO SIGMA INVESTMENTS, LP2.29%0.02%1,171,8401,171,840100.00%9,573,933Mar 31, 2024
GOLDMAN SACHS GROUP INC2.50%0.00%1,281,2421,167,7291028.72%10,467,747Mar 31, 2024
VANGUARD GROUP INC5.70%0.00%2,920,028920,62746.05%23,856,629Mar 31, 2024
RAFFERTY ASSET MANAGEMENT, LLC1.63%0.03%833,681833,681100.00%6,811,174Mar 31, 2024
BALYASNY ASSET MANAGEMENT L.P.4.76%0.03%2,435,380731,11142.90%19,897,055Mar 31, 2024
CITIGROUP INC1.50%0.00%770,728635,255468.92%6,296,848Mar 31, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.4.80%1.49%2,458,996623,00033.93%20,089,997Mar 31, 2024
LAURION CAPITAL MANAGEMENT LP1.05%0.04%535,342535,342100.00%4,373,744Mar 31, 2024
DIMENSIONAL FUND ADVISORS LP1.23%0.00%632,091516,583447.23%5,164,184Mar 31, 2024
LYNX1 CAPITAL MANAGEMENT LP7.10%7.70%3,634,662500,26615.96%29,695,189Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.95%0.00%487,651487,651100.00%3,984,108Mar 31, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC1.49%0.04%764,862453,485145.64%6,248,923Mar 31, 2024
UBS GROUP AG1.36%0.00%696,677418,302150.27%5,691,851Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.72%0.00%366,600366,600100.00%2,995,122Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.76%0.01%388,193361,1031332.98%3,171,537Mar 31, 2024
ATOM INVESTORS LP0.62%0.32%316,246316,246100.00%2,583,730Mar 31, 2024
MORGAN STANLEY1.00%0.00%514,183308,842150.40%4,200,875Mar 31, 2024

As of Mar 31 2024, C4 Therapeutics's largest institutional buyer is STATE STREET CORP. The company purchased 7.00M stocks of CCCC, valued at $58.44M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
WASATCH ADVISORS LP8.45%0.18%4,328,479-2,810,470-39.37%35,363,673Mar 31, 2024
POINT72 ASSET MANAGEMENT, L.P.1.77%0.02%906,472-1,054,887-53.78%7,405,876Mar 31, 2024
MARSHALL WACE, LLP0.29%0.00%146,644-976,417-86.94%1,198,082Mar 31, 2024
BLACKROCK INC.1.77%0.00%905,006-898,427-49.82%7,393,899Mar 31, 2024
ARROWMARK COLORADO HOLDINGS LLC2.52%0.12%1,291,939-845,442-39.55%10,555,142Mar 31, 2024
INVESCO LTD.0.08%0.00%38,536-653,546-94.43%314,839Mar 31, 2024
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC2.23%0.75%1,142,210-500,000-30.45%9,331,856Mar 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/4.13%0.00%2,115,477-443,003-17.32%17,284,000Mar 31, 2024
COMMODORE CAPITAL LP6.66%1.86%3,410,384-389,616-10.25%27,862,837Mar 31, 2024
MILLENNIUM MANAGEMENT LLC1.12%0.00%575,131-157,014-21.45%4,698,820Mar 31, 2024
AQR CAPITAL MANAGEMENT LLC----148,610-100.00%-Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC0.04%0.00%21,993-147,423-87.02%179,000Mar 31, 2024
JANE STREET GROUP, LLC0.11%0.00%54,114-144,557-72.76%442,111Mar 31, 2024
SCHONFELD STRATEGIC ADVISORS LLC----102,379-100.00%-Mar 31, 2024
RAYMOND JAMES & ASSOCIATES----100,984-100.00%-Mar 31, 2024
JACOBS LEVY EQUITY MANAGEMENT, INC----100,370-100.00%-Mar 31, 2024
BANK OF MONTREAL /CAN/----76,800-100.00%-Mar 31, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.10%0.01%49,000-75,000-60.48%400,330Mar 31, 2024
CITADEL ADVISORS LLC0.30%0.00%154,500-58,400-27.43%1,262,265Mar 31, 2024
683 CAPITAL MANAGEMENT, LLC----55,602-100.00%-Mar 31, 2024

As of Mar 31 2024, C4 Therapeutics's biggest institutional seller is WASATCH ADVISORS LP. The company sold -2.81M shares of CCCC, valued at $35.36M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SILVERARC CAPITAL MANAGEMENT, LLC2.80%3.26%1,435,9311,435,931100.00%11,731,556Mar 31, 2024
RAFFERTY ASSET MANAGEMENT, LLC1.63%0.03%833,681833,681100.00%6,811,174Mar 31, 2024
LAURION CAPITAL MANAGEMENT LP1.05%0.04%535,342535,342100.00%4,373,744Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.95%0.00%487,651487,651100.00%3,984,108Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.72%0.00%366,600366,600100.00%2,995,122Mar 31, 2024
ATOM INVESTORS LP0.62%0.32%316,246316,246100.00%2,583,730Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.50%0.00%257,800257,800100.00%2,106,226Mar 31, 2024
TREXQUANT INVESTMENT LP0.44%0.04%224,487224,487100.00%1,834,059Mar 31, 2024
WELLINGTON MANAGEMENT GROUP LLP0.38%0.00%197,109197,109100.00%1,610,380Mar 31, 2024
PROFUND ADVISORS LLC0.25%0.04%126,250126,250100.00%1,031,463Mar 31, 2024
JUMP FINANCIAL, LLC0.23%0.03%116,507116,507100.00%951,862Mar 31, 2024
ENGINEERS GATE MANAGER LP0.20%0.02%104,367104,367100.00%852,678Mar 31, 2024
SUSQUEHANNA PORTFOLIO STRATEGIES, LLC0.18%0.02%91,12791,127100.00%744,508Mar 31, 2024
CAPITAL FUND MANAGEMENT S.A.0.15%0.00%76,79176,791100.00%627,382Mar 31, 2024
QUEST PARTNERS LLC0.13%0.09%64,00164,001100.00%522,888Mar 31, 2024
MARATHON TRADING INVESTMENT MANAGEMENT LLC0.13%0.04%64,00064,000100.00%522,880Mar 31, 2024
WALLEYE CAPITAL LLC0.10%0.00%52,30452,304100.00%427,324Mar 31, 2024
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC0.10%0.02%51,36551,365100.00%419,652Mar 31, 2024
GSA CAPITAL PARTNERS LLP0.10%0.03%48,76348,763100.00%398,000Mar 31, 2024
GRAHAM CAPITAL MANAGEMENT, L.P.0.09%0.01%47,44947,449100.00%387,658Mar 31, 2024
FOX RUN MANAGEMENT, L.L.C.0.08%0.07%41,73241,732100.00%340,950Mar 31, 2024
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD.0.08%0.00%41,44541,445100.00%259,922Mar 31, 2024
E FUND MANAGEMENT CO., LTD.0.08%0.02%39,39639,396100.00%321,865Mar 31, 2024
COMMONWEALTH EQUITY SERVICES, LLC0.08%0.00%39,00239,002100.00%319,000Mar 31, 2024
WALLEYE CAPITAL LLC0.07%0.00%34,40034,400100.00%281,048Mar 31, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)0.06%0.00%28,59028,590100.00%233,580Mar 31, 2024
ENTRYPOINT CAPITAL, LLC0.06%0.21%28,51628,516100.00%232,976Mar 31, 2024
FARALLON CAPITAL MANAGEMENT LLC0.05%0.00%28,00028,000100.00%228,760Mar 31, 2024
WALLEYE TRADING LLC0.05%0.00%24,79424,794100.00%202,567Mar 31, 2024
POLYMER CAPITAL MANAGEMENT (HK) LTD0.04%0.05%21,90621,906100.00%178,972Mar 31, 2024
CAXTON ASSOCIATES LP0.04%0.01%21,00221,002100.00%171,586Mar 31, 2024
STIFEL FINANCIAL CORP0.04%0.00%20,01220,012100.00%163,496Mar 31, 2024
LMR PARTNERS LLP0.04%0.00%19,56319,563100.00%159,830Mar 31, 2024
OCCUDO QUANTITATIVE STRATEGIES LP0.04%0.03%18,31718,317100.00%149,650Mar 31, 2024
BREVAN HOWARD CAPITAL MANAGEMENT LP0.03%0.00%15,52615,526100.00%126,847Mar 31, 2024
ENTROPY TECHNOLOGIES, LP0.03%0.01%15,39115,391100.00%125,744Mar 31, 2024
WALLEYE CAPITAL LLC0.03%0.00%14,90014,900100.00%121,733Mar 31, 2024
MACQUARIE GROUP LTD0.01%-4,0094,009100.00%33Mar 31, 2024
PACER ADVISORS, INC.0.01%0.00%3,9293,929100.00%32,100Mar 31, 2024
WALLEYE TRADING LLC0.00%-2,2002,200100.00%17,974Mar 31, 2024
AQUATIC CAPITAL MANAGEMENT LLC0.00%0.00%1,4001,400100.00%11,438Mar 31, 2024
PISCATAQUA SAVINGS BANK0.00%0.00%600600100.00%4,902,000Mar 31, 2024
US BANCORP \DE\0.00%-3939100.00%319Mar 31, 2024

C4 Therapeutics's largest new institutional shareholder by number of shares is SILVERARC CAPITAL MANAGEMENT, LLC, purchased 1.44M shares, valued at $11.73M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
AQR CAPITAL MANAGEMENT LLC----148,610-100.00%-Mar 31, 2024
SCHONFELD STRATEGIC ADVISORS LLC----102,379-100.00%-Mar 31, 2024
RAYMOND JAMES & ASSOCIATES----100,984-100.00%-Mar 31, 2024
JACOBS LEVY EQUITY MANAGEMENT, INC----100,370-100.00%-Mar 31, 2024
BANK OF MONTREAL /CAN/----76,800-100.00%-Mar 31, 2024
683 CAPITAL MANAGEMENT, LLC----55,602-100.00%-Mar 31, 2024
B. METZLER SEEL. SOHN & CO. AG----49,037-100.00%-Mar 31, 2024
CORNERCAP INVESTMENT COUNSEL INC----46,286-100.00%-Mar 31, 2024
HSBC HOLDINGS PLC----30,200-100.00%-Mar 31, 2024
ALGERT GLOBAL LLC----27,960-100.00%-Mar 31, 2024
MILLENNIUM MANAGEMENT LLC----25,000-100.00%-Mar 31, 2024
CRESSET ASSET MANAGEMENT, LLC----25,000-100.00%-Mar 31, 2024
LIGHTHOUSE INVESTMENT PARTNERS, LLC----21,981-100.00%-Mar 31, 2024
XTX TOPCO LTD----21,203-100.00%-Mar 31, 2024
BANK OF NEW YORK MELLON CORP----20,682-100.00%-Mar 31, 2024
Y-INTERCEPT (HONG KONG) LTD----18,823-100.00%-Mar 31, 2024
MIRABELLA FINANCIAL SERVICES LLP----18,400-100.00%-Mar 31, 2024
PRELUDE CAPITAL MANAGEMENT, LLC----17,749-100.00%-Mar 31, 2024
BOOTHBAY FUND MANAGEMENT, LLC----13,400-100.00%-Mar 31, 2024
LAZARD ASSET MANAGEMENT LLC----12,375-100.00%-Mar 31, 2024
SHERBROOKE PARK ADVISERS LLC----11,131-100.00%-Mar 31, 2024
CUTLER GROUP LLC / CA----10,600-100.00%-Mar 31, 2024
SHAY CAPITAL LLC----10,000-100.00%-Mar 31, 2024
FNY INVESTMENT ADVISERS, LLC----8,800-100.00%-Mar 31, 2024
HEADLANDS TECHNOLOGIES LLC----6,880-100.00%-Mar 31, 2024
POINT72 ASIA (SINGAPORE) PTE. LTD.----3,928-100.00%-Mar 31, 2024
FAIRFIELD, BUSH & CO.----200-100.00%-Mar 31, 2024

C4 Therapeutics's largest sold out institutional shareholder by shares sold is AQR CAPITAL MANAGEMENT LLC, sold -0.15M shares, valued at -, as of undefined.

C4 Therapeutics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
Clough Global Equity Fund1.43%88,500--Jan 31, 2024
Clough Global Opportunities Fund0.41%161,281--Jan 31, 2024
Clough Funds Trust0.34%14,000--Jan 31, 2023
WASATCH FUNDS TRUST0.30%2,816,041-1,870,419-39.91%Mar 31, 2024
MERIDIAN FUND INC0.27%953,906-203,700-17.60%Dec 29, 2023
CORNERCAP GROUP OF FUNDS /VA/0.14%9,815--Sep 30, 2022
VANGUARD EXPLORER FUND0.13%1,651,861--Jan 31, 2024
BlackRock Advantage SMID Cap Fund, Inc.0.13%24,124-632-2.55%Dec 29, 2023
PRUDENTIAL SECTOR FUNDS, INC.0.10%209,981--Feb 29, 2024
T. Rowe Price New Horizons Fund, Inc.0.09%1,406,070-357,986-20.29%Dec 31, 2023
ROYCE MICRO-CAP TRUST, INC.0.09%48,13542,235715.85%Dec 31, 2023
T. Rowe Price Health Sciences Fund, Inc.0.08%381,492--Dec 31, 2023
BlackRock Health Sciences Trust II0.07%201,293--Dec 31, 2023
VANGUARD VALLEY FORGE FUNDS0.06%31,822--Dec 31, 2023
T. Rowe Price Small-Cap Value Fund, Inc.0.06%468,657--Dec 31, 2023
BRIDGEWAY FUNDS INC0.05%124,000-25,000-16.78%Dec 29, 2023
Vericimetry Funds0.05%5,070--Dec 31, 2023
PRUDENTIAL JENNISON BLEND FUND, INC.0.04%26,048--Feb 29, 2024
Federated Hermes MDT Series0.03%63,459--Jan 31, 2024
T. Rowe Price Quantitative Management Funds, Inc.0.02%75,400--Dec 31, 2023
Humankind Benefit Corp0.02%439--Dec 31, 2023
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%6,192--Dec 31, 2023
T. Rowe Price Equity Series, Inc.0.01%21,403--Dec 31, 2023
VANGUARD VARIABLE INSURANCE FUNDS0.01%591,714--Dec 31, 2023
Fidelity Commonwealth Trust II0.01%74,12040,612121.20%Aug 31, 2023
QUANTITATIVE MASTER SERIES LLC0.01%65,317--Dec 31, 2023
FIDELITY SELECT PORTFOLIOS0.01%579,281--Feb 29, 2024
ETFis Series Trust I0.01%12,350--Jan 31, 2024
FIRST TRUST EXCHANGE-TRADED FUND0.01%86,239--Dec 31, 2023
FIDELITY ADVISOR SERIES VII0.01%69,700--Jan 31, 2024
INVESCO EXCHANGE-TRADED FUND TRUST0.01%649,186592,9491054.38%Jan 31, 2024
AIM EQUITY FUNDS (INVESCO EQUITY FUNDS)0.01%104,040--Jan 31, 2024
VANGUARD INDEX FUNDS0.01%2,577,639729,06539.44%Dec 31, 2023
Harbor ETF Trust0.00%23,3001980.86%Jan 31, 2024
FIDELITY COMMONWEALTH TRUST0.00%15,612--Feb 29, 2024
VANGUARD QUANTITATIVE FUNDS0.00%41,4003,6009.52%Dec 31, 2023
TIAA SEPARATE ACCOUNT VA 10.00%970--Dec 31, 2023
FIDELITY MT VERNON STREET TRUST0.00%105,714--Feb 29, 2024
DRIEHAUS MUTUAL FUNDS0.00%27,203--Dec 29, 2023
ALPS ETF Trust0.00%30,916--Feb 29, 2024
NEUBERGER BERMAN EQUITY FUNDS0.00%23,991--Feb 29, 2024
HARBOR FUNDS0.00%54,762-572-1.03%Jan 31, 2024
TIAA-CREF LIFE FUNDS0.00%6,367--Dec 31, 2023
Brinker Capital Destinations Trust0.00%95,550--Feb 29, 2024
AIM COUNSELOR SERIES TRUST (INVESCO COUNSELOR SERIES TRUST)0.00%311,185--Feb 29, 2024
SCHWAB STRATEGIC TRUST0.00%237,8028,0903.52%Feb 29, 2024
Calvert Variable Products, Inc.0.00%2,962--Dec 31, 2023
FIDELITY CONCORD STREET TRUST0.00%233,668-122,511-34.40%Feb 29, 2024
Principal Exchange-Traded Funds0.00%13,238-1,515-10.27%Mar 31, 2024
JANUS INVESTMENT FUND0.00%335,365--Dec 31, 2023
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%27,453--Dec 31, 2023
Direxion Shares ETF Trust0.00%139,285--Jan 31, 2024
MML SERIES INVESTMENT FUND0.00%6,851--Dec 31, 2023
T. Rowe Price Index Trust, Inc.0.00%12,400--Feb 29, 2024
BlackRock ETF Trust0.00%610--Jan 31, 2024
Dimensional ETF Trust0.00%282,498257,4221026.57%Jan 31, 2024
Voya VARIABLE PORTFOLIOS INC0.00%16,458--Dec 31, 2023
AMERICAN CENTURY ETF TRUST0.00%45,55011,47533.68%Feb 29, 2024
VANGUARD HORIZON FUNDS0.00%8,027--Dec 31, 2023
RBB FUND, INC.0.00%33,996--Feb 29, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%49,047--Dec 31, 2023
NORTHWESTERN MUTUAL SERIES FUND INC0.00%41,400--Dec 31, 2023
OHIO NATIONAL FUND INC0.00%6,485--Dec 31, 2023
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%1,389--Dec 31, 2023
Trust for Advised Portfolios0.00%4,903--Dec 31, 2023
VARIABLE INSURANCE PRODUCTS FUND II0.00%2,283-42,472-94.90%Dec 31, 2023
VANGUARD WORLD FUND0.00%39,029--Feb 29, 2024
FLEXSHARES TRUST0.00%12,351--Jan 31, 2024
FIDELITY SALEM STREET TRUST0.00%367,861--Feb 29, 2024
Victory Portfolios II0.00%7,482--Dec 31, 2023
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%10,300--Dec 31, 2023
Forethought Variable Insurance Trust0.00%435--Dec 29, 2023
GOLDMAN SACHS TRUST0.00%15,247--Feb 29, 2024
RYDEX SERIES FUNDS0.00%387--Dec 31, 2023
Guggenheim Active Allocation Fund0.00%460--Feb 29, 2024
VANGUARD SCOTTSDALE FUNDS0.00%152,164--Feb 29, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%76,94252,407213.60%Jan 31, 2024
RUSSELL INVESTMENT CO0.00%18,639--Jan 31, 2024
ProFunds0.00%533--Jan 31, 2024
SEI INSTITUTIONAL MANAGED TRUST0.00%169,023-5,160-2.96%Dec 31, 2023
RUSSELL INVESTMENT FUNDS0.00%3,528--Dec 31, 2023
VALIC Co I0.00%15,482--Feb 29, 2024
MASTER INVESTMENT PORTFOLIO0.00%4,328--Dec 31, 2023
NATIONWIDE MUTUAL FUNDS0.00%6,3736,1342566.53%Jan 31, 2024
RYDEX DYNAMIC FUNDS0.00%192--Dec 31, 2023
PENN SERIES FUNDS INC0.00%1,300--Dec 29, 2023
SPDR SERIES TRUST0.00%1,716,867--Dec 31, 2023
MORGAN STANLEY INSTITUTIONAL FUND INC0.00%1,580--Dec 31, 2023
RYDEX VARIABLE TRUST0.00%25--Dec 31, 2023
HC CAPITAL TRUST0.00%585--Dec 31, 2023
COLLEGE RETIREMENT EQUITIES FUND0.00%20,231--Dec 31, 2023
MORGAN STANLEY PATHWAY FUNDS0.00%1,683--Feb 29, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%35,100--Dec 31, 2023
SUNAMERICA SERIES TRUST0.00%4,820--Jan 31, 2024
PACE SELECT ADVISORS TRUST0.00%4,341--Jan 31, 2024
Fidelity Rutland Square Trust II0.00%16,000--Feb 29, 2024
EQ ADVISORS TRUST0.00%14,8956,30573.40%Dec 31, 2023
PROSHARES TRUST0.00%3,138--Feb 29, 2024
Franklin Alternative Strategies Funds0.00%6,325--Feb 29, 2024
COLUMBIA FUNDS SERIES TRUST I0.00%54,250--Feb 29, 2024

C4 Therapeutics's largest mutual fund holder by % of total assets is "Clough Global Equity Fund", owning 88.50K shares, compromising 1.43% of its total assets.

C4 Therapeutics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 2410921.11%
31 Dec, 239012.50%
30 Sep, 2380-15.79%
30 Jun, 2395-17.39%
31 Mar, 231153.60%
31 Dec, 221110.91%
30 Sep, 22110-
30 Jun, 22110-12.00%
31 Mar, 221256.84%
31 Dec, 211174.46%
30 Sep, 211125.66%
30 Jun, 2110629.27%
31 Mar, 21829.33%
31 Dec, 2075-

As of 31 Mar 24, 109 institutions are holding C4 Therapeutics's shares, representing an increase of 21.11% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 2457,968,59026.55%
31 Dec, 2345,805,46833.19%
30 Sep, 2334,391,3561.51%
30 Jun, 2333,878,897-8.49%
31 Mar, 2337,021,715-5.13%
31 Dec, 2239,025,432-0.67%
30 Sep, 2239,287,502-0.01%
30 Jun, 2239,289,9945.66%
31 Mar, 2237,185,2473.82%
31 Dec, 2135,815,8513.95%
30 Sep, 2134,454,4387.93%
30 Jun, 2131,921,95327.22%
31 Mar, 2125,092,72710.51%
31 Dec, 2022,706,751-

C4 Therapeutics (CCCC) has 57.97M shares outstanding as of 31 Mar 24, up 26.55% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 24113.18%1.31%
31 Dec, 2393.08%1.89%
30 Sep, 2370.10%1.47%
30 Jun, 2369.09%1.21%
31 Mar, 2375.50%1.18%
31 Dec, 2279.87%1.24%
30 Sep, 2280.31%1.24%
30 Jun, 2280.47%1.38%
31 Mar, 2276.30%1.40%
31 Dec, 2173.86%1.46%
30 Sep, 2171.05%1.34%
30 Jun, 2172.79%2.15%
31 Mar, 2158.24%1.88%
31 Dec, 2055.70%-

As of 31 Mar 24, C4 Therapeutics is held by 113.18% institutional shareholders, representing a 1.31% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 246927.78%
31 Dec, 235442.11%
30 Sep, 2338-26.92%
30 Jun, 2352-17.46%
31 Mar, 236314.55%
31 Dec, 2255-11.29%
30 Sep, 2262-3.13%
30 Jun, 2264-11.11%
31 Mar, 227214.29%
31 Dec, 2163-11.27%
30 Sep, 2171-10.13%
30 Jun, 217975.56%
31 Mar, 2145-40.00%
31 Dec, 2075-

69 institutional shareholders have increased their position in CCCC stock as of 31 Mar 24 compared to 54 in the previous quarter (a 27.78% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 2425-
31 Dec, 2325-16.67%
30 Sep, 2330-11.76%
30 Jun, 2334-2.86%
31 Mar, 23359.38%
31 Dec, 22323.23%
30 Sep, 2231-3.13%
30 Jun, 22326.67%
31 Mar, 2230-6.25%
31 Dec, 213260.00%
30 Sep, 212053.85%
30 Jun, 2113-38.10%
31 Mar, 2121-
31 Dec, 20--

25 institutional shareholders have reduced their position in CCCC stock as of 31 Mar 24 compared to 25 in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 2410921.11%57,968,59026.55%113.18%1.31%6927.78%25-
31 Dec, 239012.50%45,805,46833.19%93.08%1.89%5442.11%25-16.67%
30 Sep, 2380-15.79%34,391,3561.51%70.10%1.47%38-26.92%30-11.76%
30 Jun, 2395-17.39%33,878,897-8.49%69.09%1.21%52-17.46%34-2.86%
31 Mar, 231153.60%37,021,715-5.13%75.50%1.18%6314.55%359.38%
31 Dec, 221110.91%39,025,432-0.67%79.87%1.24%55-11.29%323.23%
30 Sep, 22110-39,287,502-0.01%80.31%1.24%62-3.13%31-3.13%
30 Jun, 22110-12.00%39,289,9945.66%80.47%1.38%64-11.11%326.67%
31 Mar, 221256.84%37,185,2473.82%76.30%1.40%7214.29%30-6.25%
31 Dec, 211174.46%35,815,8513.95%73.86%1.46%63-11.27%3260.00%
30 Sep, 211125.66%34,454,4387.93%71.05%1.34%71-10.13%2053.85%
30 Jun, 2110629.27%31,921,95327.22%72.79%2.15%7975.56%13-38.10%
31 Mar, 21829.33%25,092,72710.51%58.24%1.88%45-40.00%21-
31 Dec, 2075-22,706,751-55.70%-75---

C4 Therapeutics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 08, 2024Boyle Scott Nofficer Chief Business OfficerD-ReturnSell115,000$33.23$3.82M-
Mar 08, 2024Fisher Stewartofficer Chief Scientific OfficerD-ReturnSell94,950$45.54$4.32M-
Mar 08, 2024Fisher Stewartofficer Chief Scientific OfficerD-ReturnSell118,000$22.71$2.68M-
Mar 08, 2024Schick Kellyofficer Chief People OfficerD-ReturnSell92,000$37.46$3.45M-
Mar 08, 2024Schick Kellyofficer Chief People OfficerD-ReturnSell78,500$22.71$1.78M-
Mar 08, 2024Adams Kendraofficer Chief Financial OfficerD-ReturnSell45,000$22.71$1.02M-
Mar 08, 2024Siegel Jolieofficer Chief Legal OfficerD-ReturnSell90,000$22.71$2.04M-

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 10, 2024Mossler Markofficer Chief Accounting OfficerA-AwardBuy27,430$7.31$200.51K27,430
Apr 10, 2024Mossler Markofficer Chief Accounting OfficerA-AwardBuy18,290--19,790
Apr 02, 2024Anderson Kenneth Carldirector-A-AwardBuy1,389$8.10$11.25K112,351
Apr 02, 2024Dubin Glenndirector-A-AwardBuy1,358$8.10$11.00K22,075
Apr 02, 2024GROGAN DONNA ROYdirector-A-AwardBuy1,697$8.10$13.75K23,632
Mar 08, 2024Boyle Scott Nofficer Chief Business OfficerA-AwardBuy115,000$19.00$2.19M115,000
Mar 08, 2024Boyle Scott Nofficer Chief Business OfficerD-ReturnSell115,000$33.23$3.82M-
Mar 08, 2024Fisher Stewartofficer Chief Scientific OfficerA-AwardBuy118,000$19.00$2.24M118,000
Mar 08, 2024Fisher Stewartofficer Chief Scientific OfficerA-AwardBuy94,950$19.00$1.80M94,950
Mar 08, 2024Fisher Stewartofficer Chief Scientific OfficerD-ReturnSell94,950$45.54$4.32M-
Mar 08, 2024Fisher Stewartofficer Chief Scientific OfficerD-ReturnSell118,000$22.71$2.68M-
Mar 08, 2024Schick Kellyofficer Chief People OfficerA-AwardBuy92,000$19.00$1.75M92,000
Mar 08, 2024Schick Kellyofficer Chief People OfficerA-AwardBuy78,500$19.00$1.49M78,500
Mar 08, 2024Schick Kellyofficer Chief People OfficerD-ReturnSell92,000$37.46$3.45M-
Mar 08, 2024Schick Kellyofficer Chief People OfficerD-ReturnSell78,500$22.71$1.78M-
Mar 08, 2024Adams Kendraofficer Chief Financial OfficerA-AwardBuy45,000$19.00$855.00K45,000
Mar 08, 2024Adams Kendraofficer Chief Financial OfficerD-ReturnSell45,000$22.71$1.02M-
Mar 08, 2024Siegel Jolieofficer Chief Legal OfficerA-AwardBuy90,000$19.00$1.71M90,000
Mar 08, 2024Siegel Jolieofficer Chief Legal OfficerA-AwardBuy84,850$19.00$1.61M84,850
Mar 08, 2024Siegel Jolieofficer Chief Legal OfficerD-ReturnSell90,000$22.71$2.04M-

The last insider sell of C4 Therapeutics's stock was made by Boyle Scott N on Mar 08 2024, selling 115,000 shares at $33.23 per share (valued at $3.82M).

C4 Therapeutics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20243--
Q1 20242514178.57%
Q4 20234--
Q3 20231818100.00%
Q2 20239--
Q1 20232516156.25%
Q4 202252250.00%
Q3 202263200.00%
Q2 20221612133.33%
Q1 20221910190.00%
Q4 2021111291.67%
Q3 202194320.93%
Q2 2021207285.71%
Q1 2021116183.33%
Q4 2020294072.50%

3 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by C4 Therapeutics's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024---
Q1 2024---
Q4 2023---
Q3 2023---
Q2 2023---
Q1 20231--
Q4 2022---
Q3 2022---
Q2 20221--
Q1 2022-2-
Q4 2021-6-
Q3 2021-39-
Q2 2021-4-
Q1 2021---
Q4 20203--

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of C4 Therapeutics's stocks.

C4 Therapeutics Peer Ownership


TickerCompany
MLYSMineralys Therapeutics, Inc.
RZLTRezolute, Inc.
FHTXFoghorn Therapeutics Inc.
CYTCyteir Therapeutics, Inc.
ELYMEliem Therapeutics, Inc.
KYMRKymera Therapeutics, Inc.
ARVNArvinas, Inc.
PRLDPrelude Therapeutics Incorporated
IPSCCentury Therapeutics, Inc.
EWTXEdgewise Therapeutics, Inc.
NRIXNurix Therapeutics, Inc.
RVMDRevolution Medicines, Inc. Warrant
CGEMCullinan Oncology, Inc.
GLUEMonte Rosa Therapeutics, Inc.
STTKShattuck Labs, Inc.

CCCC Ownership FAQ


C4 Therapeutics is owned by institutional shareholders (113.18%), insiders (11.74%), and public (-24.93%). The largest institutional shareholder of C4 Therapeutics is STATE STREET CORP (13.97% of total shares) and the top mutual fund owner is Clough Global Equity Fund (1.43% of total shares).

C4 Therapeutics's major institutional shareholders are STATE STREET CORP, RA CAPITAL MANAGEMENT, L.P., WASATCH ADVISORS LP, LYNX1 CAPITAL MANAGEMENT LP, and COMMODORE CAPITAL LP. The top five shareholders own together 45.70% of the company's share outstanding.

As of Mar 2024, there are 109 institutional shareholders of C4 Therapeutics.

STATE STREET CORP owns 7.15M shares of C4 Therapeutics, representing 13.97% of the company's total shares outstanding, valued at $58.44M (as of Mar 2024).

As of Mar 2024, RA CAPITAL MANAGEMENT, L.P holds 4.88M shares of C4 Therapeutics (CCCC), compromising 9.52% of the company, valued at $39.85M.

WASATCH ADVISORS LP is the third largest holder of C4 Therapeutics. The company owns 4.33M of the company's shares outstanding (worth $35.36M).